Scientists track side effects of monkeypox shot in congo health workers

NCT ID NCT05734508

Summary

This study monitored the safety of the Jynneos monkeypox vaccine in 500 healthcare staff and researchers in the Democratic Republic of the Congo. Participants received two doses of the vaccine and were followed for 28 days after their last shot to track any side effects. The goal was to understand how common and serious side effects are in this real-world group at high risk of exposure.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institut National de Rescherche Biomédicale (INRB)

    Kinshasa, Democratic Republic of the Congo

  • L'Hôpital Général de Référence de Kole

    Kole, Democratic Republic of the Congo

  • L'Hôpital Général de Référence de Tunda

    Tunda, Democratic Republic of the Congo

Conditions

Explore the condition pages connected to this study.